Literature DB >> 24227865

Comparative analysis of hepatitis B virus polymerase sequences required for viral RNA binding, RNA packaging, and protein priming.

Scott A Jones1, Daniel N Clark, Feng Cao, John E Tavis, Jianming Hu.   

Abstract

Hepatitis B virus replicates a DNA genome through reverse transcription of a pregenomic RNA (pgRNA) by using a multifunctional polymerase (HP). A critical function of HP is its specific association with a viral RNA signal, termed ε (Hε), located on pgRNA, which is required for specific packaging of pgRNA into viral nucleocapsids and initiation of viral reverse transcription. HP initiates reverse transcription by using itself as a protein primer (protein priming) and Hε as the obligatory template. HP is made up of four domains, including the terminal protein (TP), the spacer, the reverse transcriptase (RT), and the RNase H domains. A recently developed, Hε-dependent, in vitro protein priming assay was used in this study to demonstrate that almost the entire TP and RT domains and most of the RNase H domain were required for protein priming. Specific residues within TP, RT, and the spacer were identified as being critical for HP-Hε binding and/or protein priming. Comparison of HP sequence requirements for Hε binding, pgRNA packaging, and protein priming allowed the classification of the HP mutants into five groups, each with distinct effects on these complex and related processes. Detailed characterization of HP requirements for these related and essential functions of HP will further elucidate the mechanisms of its multiple functions and aid in the targeting of these functions for antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24227865      PMCID: PMC3911602          DOI: 10.1128/JVI.02852-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Hydrophobic residues of terminal protein domain of hepatitis B virus polymerase contribute to distinct steps in viral genome replication.

Authors:  Youn-Chul Shin; Chunkyu Ko; Wang-Shick Ryu
Journal:  FEBS Lett       Date:  2011-11-10       Impact factor: 4.124

2.  Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction.

Authors:  R E Lanford; Y H Kim; H Lee; L Notvall; B Beames
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

3.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Mutagenesis of a hepatitis B virus reverse transcriptase yields temperature-sensitive virus.

Authors:  C Seeger; E H Leber; L K Wiens; J Hu
Journal:  Virology       Date:  1996-08-15       Impact factor: 3.616

5.  Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.

Authors:  J Hu; C Seeger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

6.  TP-RT domain interactions of duck hepatitis B virus reverse transcriptase in cis and in trans during protein-primed initiation of DNA synthesis in vitro.

Authors:  Rajeev K Boregowda; Christina Adams; Jianming Hu
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

7.  Four conserved cysteine residues of the hepatitis B virus polymerase are critical for RNA pregenome encapsidation.

Authors:  Seahee Kim; Jehan Lee; Wang-Shick Ryu
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

8.  Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding.

Authors:  Michael Stahl; Jürgen Beck; Michael Nassal
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

9.  Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.

Authors:  Jianming Hu; Morgan Boyer
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.

Authors:  M Weber; V Bronsema; H Bartos; A Bosserhoff; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more
  20 in total

1.  Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay.

Authors:  Shogo Nakajima; Koichi Watashi; Kento Fukano; Senko Tsukuda; Kousho Wakae; Hideki Aizaki; Masamichi Muramatsu; Takaji Wakita; Tetsuya Toyoda
Journal:  J Gastroenterol       Date:  2019-11-25       Impact factor: 7.527

2.  RNA-Binding Motif Protein 24 (RBM24) Is Involved in Pregenomic RNA Packaging by Mediating Interaction between Hepatitis B Virus Polymerase and the Epsilon Element.

Authors:  Zhe Wen; Chunchen Wu; Xinwen Chen; Yongxuan Yao; Bo Yang; Yingshan Chen; Hui Wang; Xue Hu; Yuan Zhou; Xiuzhu Gao; Mengji Lu; Junqi Niu
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 3.  Hepadnavirus Genome Replication and Persistence.

Authors:  Jianming Hu; Christoph Seeger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

4.  Mapping of Functional Subdomains in the Terminal Protein Domain of Hepatitis B Virus Polymerase.

Authors:  Daniel N Clark; John M Flanagan; Jianming Hu
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

5.  Unveiling the roles of HBV polymerase for new antiviral strategies.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

6.  Frangulosid as a novel hepatitis B virus DNA polymerase inhibitor: a virtual screening study.

Authors:  Mokhtar Nosrati; Zahra Shakeran; Zainab Shakeran
Journal:  In Silico Pharmacol       Date:  2018-05-17

7.  Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.

Authors:  Nuruddin Unchwaniwala; Nathan M Sherer; Daniel D Loeb
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 8.  Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Antiviral Res       Date:  2015-09-25       Impact factor: 5.970

9.  In Vitro Assays for RNA Binding and Protein Priming of Hepatitis B Virus Polymerase.

Authors:  Daniel N Clark; Scott A Jones; Jianming Hu
Journal:  Methods Mol Biol       Date:  2017

Review 10.  Recent Advances in Hepatitis B Treatment.

Authors:  Georgia-Myrto Prifti; Dimitrios Moianos; Erofili Giannakopoulou; Vasiliki Pardali; John E Tavis; Grigoris Zoidis
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.